Paxlovid May Lower Long COVID Risk, VA Study Suggests

(MedPage Today) -- Use of nirmatrelvir-ritonavir (Paxlovid) in older adults with risk factors for severe disease was associated with a roughly 25% lower risk of a post-COVID condition (PCC), a retrospective study of Veterans Affairs data showed...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news